Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Aprepitant 125mg capsules and Aprepitant 80mg capsules |
| BNF code | 0406000ADAAACAC |
| Virtual Therapeutic Moiety | Aprepitant |
| Date identifier became valid | 17 Oct 2018 |
| Previous product identifier | 410959002 |
| Basis of preferred name | Other |
| Date of name applicability | 28 Feb 2007 |
| Previous name | Aprepitant 125mg capsules and Aprepitant 80mg capsules |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Combination product | Combination Product |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Not applicable |
| Dose Form | |
|---|---|
| Formulation | Not applicable |
| Drug Route | |
| Route | Route of administration not applicable |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Aprepitant 125mg capsules and Aprepitant 80mg capsules (A A H Pharmaceuticals Ltd) | |
| Aprepitant 125mg capsules and Aprepitant 80mg capsules (Accord-UK Ltd) | |
| Aprepitant 125mg capsules and Aprepitant 80mg capsules (Viatris UK Healthcare Ltd) | |
| Aprepitant 125mg capsules and Aprepitant 80mg capsules (Zentiva Pharma UK Ltd) | |
| Emend 125mg and 80mg capsules (Merck Sharp & Dohme (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Aprepitant 125mg capsules and Aprepitant 80mg capsules 3 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.